Risedronate

Known as: Risedronsäure, RISE, 1-Hydroxy-2-(3-pyridyl)ethylidene diphosphonate 
A synthetic pyridinyl bisphosphonate agent. Risedronate binds to hydroxyapatite crystals in bone and inhibits osteoclast-dependent bone resorption… (More)
National Institutes of Health

Topic mentions per year

Topic mentions per year

1980-2017
05010019802017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2009
Highly Cited
2009
BACKGROUND Persistent use of glucocorticoid drugs is associated with bone loss and increased fracture risk. Concurrent oral… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • table 2
Is this relevant?
Highly Cited
2007
Highly Cited
2007
One year after discontinuation of three year’s treatment with risedronate, BMD decreased at the lumbar spine and femoral neck and… (More)
  • figure 1
  • table 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
Highly Cited
2004
Highly Cited
2004
The effects of 7 years of risedronate treatment were evaluated in a second 2-year extension of a 3-year vertebral fracture study… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 4
  • figure 3
Is this relevant?
Highly Cited
2003
Highly Cited
2003
Changes in the level of biochemical markers of bone resorption with risedronate treatment for osteoporosis were examined as a… (More)
Is this relevant?
Highly Cited
2001
Highly Cited
2001
BACKGROUND Risedronate increases bone mineral density in elderly women, but whether it prevents hip fracture is not known… (More)
Is this relevant?
Highly Cited
2000
Highly Cited
2000
The purpose of this randomized, double-masked, placebo-controlled study was to determine the efficacy and safety of risedronate… (More)
Is this relevant?
Highly Cited
2000
Highly Cited
2000
Men and women (n = 518) receiving moderate-to-high doses of corticosteroids were enrolled in two studies with similar protocols… (More)
  • table 1
  • table 2
  • figure 1
  • table 3
  • table 4
Is this relevant?
Highly Cited
1999
Highly Cited
1999
CONTEXT Risedronate, a potent bisphosphonate, has been shown to be effective in the treatment of Paget disease of bone and other… (More)
Is this relevant?
Highly Cited
1999
Highly Cited
1999
DECLINING ESTROGEN LEVELS at menopause result in increased bone turnover and a loss of bone mass, with subsequent increases in… (More)
  • figure 1
  • table 1
  • figure 2
  • table 2
  • figure 4
Is this relevant?
Highly Cited
1995
Highly Cited
1995
Human breast cancer frequently metastasizes to the skeleton to cause osteolysis and subsequent pain, pathological fracture, and… (More)
  • figure 2
  • figure 3
  • figure 4
  • figure 5
  • figure 6
Is this relevant?